382 related articles for article (PubMed ID: 11160777)
21. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
Teter ML
Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
[No Abstract] [Full Text] [Related]
22. The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders.
Subramaniam S
Clin Exp Hypertens; 1999; 21(1-2):121-36. PubMed ID: 10052648
[TBL] [Abstract][Full Text] [Related]
23. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
24. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
Viberti G
J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
[TBL] [Abstract][Full Text] [Related]
25. [Uric acid metabolism and insulin resistance in type 2 diabetes].
Wasada T; Iwatani M
Nihon Rinsho; 2002 Aug; 60 Suppl 8():167-72. PubMed ID: 12355741
[No Abstract] [Full Text] [Related]
26. Insulin sensitizers.
Zangeneh F; Kudva YC; Basu A
Mayo Clin Proc; 2003 Apr; 78(4):471-9. PubMed ID: 12683699
[TBL] [Abstract][Full Text] [Related]
27. [Thiazolidinediones--a new class of oral antidiabetic drugs].
Jermendy G; Csermely P
Orv Hetil; 2001 Jul; 142(29):1547-54. PubMed ID: 11494746
[TBL] [Abstract][Full Text] [Related]
28. Glitazones and the potential improvement of lipid profiles in diabetes patients at high risk for cardiovascular disease.
Nass CM; Blumenthal RS
Am J Manag Care; 2000 Dec; 6(24 Suppl):S1247-56; quiz S1257-8. PubMed ID: 11142005
[TBL] [Abstract][Full Text] [Related]
29. Pleiotropic effects of thiazolidinediones.
Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
[TBL] [Abstract][Full Text] [Related]
30. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
Samraj GP; Kuritzky L; Quillen DM
Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
[No Abstract] [Full Text] [Related]
31. [Effects of thiazolidinediones on dyslipidemia in patients with type 2 diabetes. Are all equally vasoprotective?].
Haberbosch W
Herz; 2007 Feb; 32(1):51-7. PubMed ID: 17323035
[TBL] [Abstract][Full Text] [Related]
32. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
33. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
Fonseca VA
Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
[TBL] [Abstract][Full Text] [Related]
34. Type 2 diabetes, cardiovascular risk, and the link to insulin resistance.
Stolar MW; Chilton RJ
Clin Ther; 2003; 25 Suppl B():B4-31. PubMed ID: 14553864
[TBL] [Abstract][Full Text] [Related]
35. The glitazones: a new treatment for type 2 diabetes mellitus.
Bradley C
Intensive Crit Care Nurs; 2002 Jun; 18(3):189-91. PubMed ID: 12405274
[TBL] [Abstract][Full Text] [Related]
36. Thiazolidinediones--the new insulin enhancers.
Jha RJ
Clin Exp Hypertens; 1999; 21(1-2):157-66. PubMed ID: 10052651
[TBL] [Abstract][Full Text] [Related]
37. Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention.
Henry RR
Am J Med; 1998 Jul; 105(1A):20S-26S. PubMed ID: 9707264
[TBL] [Abstract][Full Text] [Related]
38. [Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].
Brogard JM; Neyrolles N; Andres E; Blicklé JF
Rev Med Interne; 1999 Aug; 20 Suppl 3():371s-378s. PubMed ID: 10480188
[TBL] [Abstract][Full Text] [Related]
39. Effects of the thiazolidinediones on cardiovascular risk factors.
Gilling L; Suwattee P; DeSouza C; Asnani S; Fonseca V
Am J Cardiovasc Drugs; 2002; 2(3):149-56. PubMed ID: 14727977
[TBL] [Abstract][Full Text] [Related]
40. "Glitazones", a prospect for non-insulin-dependent diabetes.
Petrie J; Small M; Connell J
Lancet; 1997 Jan; 349(9045):70-1. PubMed ID: 8996411
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]